Could This Tiny AI Stock Make You Millionaire?

Poet Technologies received a Lumilens order to validate its Optical Interposer platform. The order may signal commercial traction for the company's AI photonics product. Revenue remains low and dilution risk is high as the company faces execution pressure over the next 12 to 24 months. Stock prices used were from May 27, 2026.